Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Undergraduate Student Research Awards (USRA)

University of British Columbia

$6,000.00

Rapid Rebuilding of the Functional Endothelial Glycocalyx to Prevent Microvascular Damage in Severe

EF 2026-27

Résumé
"Inflammation becomes a major driver of disease when it is dysregulated. In severe inflammation such as sepsis, loss of vascular integrity and excessive immune activation lead to tissue injury and multi-organ failure. A key regulator of vascular homeostasis is the endothelial glycocalyx, a protective surface layer that limits leukocyte adhesion and maintains endothelial barrier function. During hyper-inflammatory states, rapid degradation of the glycocalyx compromises vascular integrity, promotes immune cell infiltration, and accelerates organ damage. Currently, no effective strategies exist to rapidly rebuild a functional glycocalyx in the vasculature. We therefore hypothesize that a rationally designed immunomodulatory polymer capable of restoring key glycocalyx functions can protect the vascular barrier and suppress immune-mediated endothelial injury. To test this hypothesis, we will synthesize an immunomodulatory polymer capable of forming a stable endothelial cell-surface coating (Aim 1), and examine its immunomodulatory effect in inflamed endothelial cells (Aim 2). The polymer will be synthesized by modifying linear polyglycerol with the immunoinhibitory sugar sialic acid, as demonstrated in the Kizhakkedathu laboratory. A cationic head group will promote electrostatic adsorption onto endothelial cells , enabling rapid glycocalyx reconstruction. We anticipate that this method will rapidly reconstruct the glycocalyx and reduce immune cell adhesion, and decrease inflammatory signaling. This work proposes a new therapeutic paradigm that shifts from suppressing inflammation to restoring endothelial immune tolerance."
Programme
Undergraduate Student Research Awards (USRA)
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
571585
Name
Attafuah Ideog
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Rapid Rebuilding of the Functional Endothelial Glycocalyx to Prevent Microvascular Damage in Severe
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Disease; Inflammation; Sepsis
Abstract
"Inflammation becomes a major driver of disease when it is dysregulated. In severe inflammation such as sepsis, loss of vascular integrity and excessive immune activation lead to tissue injury and multi-organ failure. A key regulator of vascular homeostasis is the endothelial glycocalyx, a protective surface layer that limits leukocyte adhesion and maintains endothelial barrier function. During hyper-inflammatory states, rapid degradation of the glycocalyx compromises vascular integrity, promotes immune cell infiltration, and accelerates organ damage. Currently, no effective strategies exist to rapidly rebuild a functional glycocalyx in the vasculature. We therefore hypothesize that a rationally designed immunomodulatory polymer capable of restoring key glycocalyx functions can protect the vascular barrier and suppress immune-mediated endothelial injury. To test this hypothesis, we will synthesize an immunomodulatory polymer capable of forming a stable endothelial cell-surface coating (Aim 1), and examine its immunomodulatory effect in inflamed endothelial cells (Aim 2). The polymer will be synthesized by modifying linear polyglycerol with the immunoinhibitory sugar sialic acid, as demonstrated in the Kizhakkedathu laboratory. A cationic head group will promote electrostatic adsorption onto endothelial cells , enabling rapid glycocalyx reconstruction. We anticipate that this method will rapidly reconstruct the glycocalyx and reduce immune cell adhesion, and decrease inflammatory signaling. This work proposes a new therapeutic paradigm that shifts from suppressing inflammation to restoring endothelial immune tolerance."
Competitiondate
202605
Approvedterm2
0 yr 4 mths
Pinamesdelim
Attafuah, Ideog
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~